Literature DB >> 28733470

Dendritic cell-targeted lentiviral vector immunization uses pseudotransduction and DNA-mediated STING and cGAS activation.

Jocelyn T Kim1,2, Yarong Liu3, Rajan P Kulkarni1,4, Kevin K Lee1, Bingbing Dai3, Geoffrey Lovely1, Yong Ouyang1, Pin Wang3, Lili Yang1,5, David Baltimore6.   

Abstract

Dendritic cell (DC) activation and antigen presentation are critical for efficient priming of T cell responses. Here, we study how lentiviral vectors (LVs) deliver antigen and activate DCs to generate T cell immunization in vivo. We report that antigenic proteins delivered in vector particles via pseudotransduction were sufficient to stimulate an antigen-specific immune response. The delivery of the viral genome encoding the antigen increased the magnitude of this response in vivo but was irrelevant in vitro. Activation of DCs by LVs was independent of MyD88, TRIF, and MAVS, ruling out an involvement of Toll-like receptor or RIG-I-like receptor signaling. Cellular DNA packaged in LV preparations induced DC activation by the host STING (stimulator of interferon genes) and cGAS (cyclic guanosine monophosphate-adenosine monophosphate synthase) pathway. Envelope-mediated viral fusion also activated DCs in a phosphoinositide 3-kinase-dependent but STING-independent process. Pseudotransduction, transduction, viral fusion, and delivery of cellular DNA collaborate to make the DC-targeted LV preparation an effective immunogen.
Copyright © 2017 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Entities:  

Year:  2017        PMID: 28733470      PMCID: PMC5845465          DOI: 10.1126/sciimmunol.aal1329

Source DB:  PubMed          Journal:  Sci Immunol        ISSN: 2470-9468


  50 in total

1.  Low-pH-dependent fusion of Sindbis virus with receptor-free cholesterol- and sphingolipid-containing liposomes.

Authors:  J M Smit; R Bittman; J Wilschut
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

2.  Green fluorescent protein: green cells do not always indicate gene expression.

Authors:  K L Nash; A M L Lever
Journal:  Gene Ther       Date:  2004-06       Impact factor: 5.250

3.  Protein transfer into human cells by VSV-G-induced nanovesicles.

Authors:  Philippe-Emmanuel Mangeot; Sandra Dollet; Mathilde Girard; Claire Ciancia; Stéphane Joly; Marc Peschanski; Vincent Lotteau
Journal:  Mol Ther       Date:  2011-07-12       Impact factor: 11.454

4.  Critical factors influencing stable transduction of human CD34(+) cells with HIV-1-derived lentiviral vectors.

Authors:  D L Haas; S S Case; G M Crooks; D B Kohn
Journal:  Mol Ther       Date:  2000-07       Impact factor: 11.454

5.  Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor-viral RNA interactions.

Authors:  Anne-Sophie Beignon; Kelli McKenna; Mojca Skoberne; Olivier Manches; Ida DaSilva; Daniel G Kavanagh; Marie Larsson; Robert J Gorelick; Jeffrey D Lifson; Nina Bhardwaj
Journal:  J Clin Invest       Date:  2005-10-13       Impact factor: 14.808

6.  Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway.

Authors:  Masahiro Yamamoto; Shintaro Sato; Hiroaki Hemmi; Katsuaki Hoshino; Tsuneyasu Kaisho; Hideki Sanjo; Osamu Takeuchi; Masanaka Sugiyama; Masaru Okabe; Kiyoshi Takeda; Shizuo Akira
Journal:  Science       Date:  2003-07-10       Impact factor: 47.728

7.  SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx.

Authors:  Nadine Laguette; Bijan Sobhian; Nicoletta Casartelli; Mathieu Ringeard; Christine Chable-Bessia; Emmanuel Ségéral; Ahmad Yatim; Stéphane Emiliani; Olivier Schwartz; Monsef Benkirane
Journal:  Nature       Date:  2011-05-25       Impact factor: 49.962

8.  In vivo toxicity of cationic micelles and liposomes.

Authors:  Kristina Bram Knudsen; Helle Northeved; Pramod E K Kumar; Anders Permin; Torben Gjetting; Thomas L Andresen; Steen Larsen; Karen Malene Wegener; Jens Lykkesfeldt; Kim Jantzen; Steffen Loft; Peter Møller; Martin Roursgaard
Journal:  Nanomedicine       Date:  2014-08-25       Impact factor: 5.307

9.  Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance.

Authors:  Laura Bonifaz; David Bonnyay; Karsten Mahnke; Miguel Rivera; Michel C Nussenzweig; Ralph M Steinman
Journal:  J Exp Med       Date:  2002-12-16       Impact factor: 14.307

10.  STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling.

Authors:  Hiroki Ishikawa; Glen N Barber
Journal:  Nature       Date:  2008-08-24       Impact factor: 49.962

View more
  6 in total

1.  Persistence of Integrase-Deficient Lentiviral Vectors Correlates with the Induction of STING-Independent CD8+ T Cell Responses.

Authors:  Céline Cousin; Marine Oberkampf; Tristan Felix; Pierre Rosenbaum; Robert Weil; Sylvie Fabrega; Valeria Morante; Donatella Negri; Andrea Cara; Gilles Dadaglio; Claude Leclerc
Journal:  Cell Rep       Date:  2019-01-29       Impact factor: 9.423

2.  Versatile targeting system for lentiviral vectors involving biotinylated targeting molecules.

Authors:  Kathy Situ; Bernadette Anne Chua; Song Yi Bae; Aaron Samuel Meyer; Kouki Morizono
Journal:  Virology       Date:  2018-10-02       Impact factor: 3.616

Review 3.  Dendritic Cells in HIV/SIV Prophylactic and Therapeutic Vaccination.

Authors:  Eun-Ju Ko; Marjorie Robert-Guroff
Journal:  Viruses       Date:  2019-12-24       Impact factor: 5.048

4.  Toll-Like Receptor (TLR) Signaling Enables Cyclic GMP-AMP Synthase (cGAS) Sensing of HIV-1 Infection in Macrophages.

Authors:  Mohammad Adnan Siddiqui; Masahiro Yamashita
Journal:  mBio       Date:  2021-11-30       Impact factor: 7.867

5.  A preliminary study of KAT2A on cGAS-related immunity in inflammation amplification of systemic lupus erythematosus.

Authors:  Youzhou Tang; Xinyu Li; Yafang Wei; Yongchao Sun; Yeyi Yang; Xianming Zhang; Zhihao Gao; Jishi Liu; Quan Zhuang
Journal:  Cell Death Dis       Date:  2021-10-30       Impact factor: 8.469

6.  A Single Dose of NILV-Based Vaccine Provides Rapid and Durable Protection against Zika Virus.

Authors:  Min Wen Ku; François Anna; Philippe Souque; Stéphane Petres; Matthieu Prot; Etienne Simon-Loriere; Pierre Charneau; Maryline Bourgine
Journal:  Mol Ther       Date:  2020-05-20       Impact factor: 11.454

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.